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ABSTRACT
Mild acid hydrolysis of phosphomannan secreted by the yeast Hansenula holstii
(NRRLY-2448)produces twophosphomannosylfragments which differ strikingly
in their potency as inhibitors of pinocytosis ofhuman Q-glucuronidase by human
fibroblasts . The larger molecular weight polyphosphomonoester fragment is
100,000-fold more potent an inhibitor of enzyme uptake than the smaller penta-
mannosyl-monophosphate fragment . Binding to attached fibroblasts at 3 °C was
much greater with the polyphosphomonoester fragment than with the pentaman-
nosyl-monophosphate . The larger molecular weight fragment was also subject to
adsorptive pinocytosis and was taken up by fibroblasts at a rate 30-fold greater
than the rate of uptake of pentamannosyl-monophosphate . Evidence that the
polyphosphomonoester fragment is taken up by the phosphomannosyl-recognition
system that mediates uptake of lysosomal enzymes includes ; (a) its pinocytosis is
inhibited by the same compounds that competitively inhibit enzyme pinocytosis
(mannose-6-phosphate and phosphomannan from Saccharomyces cerevisiae mu-
tant mnn-1) ; (b) alkaline phosphatase treatment greatly reduces its susceptibility
to pinocytosis ; (c) its pinocytosis is competitively inhibited by high-uptake human
a-glucuronidase ; and (d) this inhibition by high-uptake enzyme is dramatically
reduced by prior treatment of the enzyme with alkaline phosphatase or endogly-
cosidase-H .
Endoglycosidase-H treatment of human a-glucuronidase dramatically reduced
its susceptibility to pinocytosis by fibroblasts . The phosphomannosyl components
of high-uptake enzyme released by endoglycosidase-H treatment were much less
effective inhibitors of polyphosphomonoester pinocytosis than when present on
the phosphomannosyl-enzyme . These results suggest that high-uptake acid hydro-
lases may be polyvalent ligands analogous to the polyphosphomonoester mannan
fragment whose pinocytosis depends on interaction of more than one phospho-
mannosyl recognition marker with pinocytosis receptors on fibroblasts.
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Many lysosomal acid hydrolases are subject to
adsorptive pinocytosis by fibroblasts, i.e., their
uptake displays the saturability and selectivity ex-
pected of a receptor-mediated process (3, 13, 20,
26) . Hickman and Neufeld (10) suggested that
many acid hydrolases share acommon recognition
marker for uptake, and suggested further (11) that
the recognition marker may reside in the carbo-
hydrate portion of the glycoprotein hydrolases.
Glaser et al . (8) reported that the fraction of a
given acid hydrolase which was subject to adsorp-
tive pinocytosis by fibroblasts corresponded to a
subpopulation of enzyme molecules that was rel-
atively acidic, and showed that this "high-uptake"
form of the enzyme was converted to less acidic
"low-uptake" forms after pinocytosis by fibro-
blasts .
That phosphomannose is the acidic group in the
common recognition marker for uptake by fibro-
blasts was first suggested by Kaplan, Achord, and
Sly (13) on the basis of studies with purified
human platelet a-glucuronidase . The presence of
phosphate on the enzyme and its role in enzyme
pinocytosis were inferred from the finding that
alkaline phosphatase treatment of "high-uptake"
human platelet /3-glucuronidase altered its electro-
phoretic properties and destroyed its ability to be
taken up by fibroblasts . Linkage of the phosphate
to a mannose-type carbohydrate was inferred from
the potent competitive inhibition of enzyme pi-
nocytosis by 6-phosphomannose . Mannose-6-
phosphate was 1,000-fold more potent an inhibitor
of enzyme pinocytosis than mannose, which had
been reported earlier to inhibit enzyme pinocytosis
(12) .
These observations were extended by studies
from this laboratory (14) to human a-glucuroni-
dase from four other tissue sources, to two addi-
tional platelet enzymes (,l3-galactosidase and a-
hexosaminidase), and to fibroblast secretion hex-
osaminidase . Sando and Neufeld (21) extended
these results to human a-L-iduronidase, the origi-
nal Hurler-corrective factor (19), and Ullrich et al.
(25) confirmed the evidence for phosphomannosyl
involvement in the pinocytosis of a number of the
enzymes mentioned above and extended these ob-
servations to human urinary arylsulfatase A,N-
acetyl-a-D-glucosaminidase, and to a pig kidney
a-mannosidase .
Part of the initial evidence implicating 6-phos-
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phomannose recognition in the uptake of acid
hydrolases by fibroblasts was the competitive in-
hibition ofuptake by phosphomannans containing
6-phosphomannose (13) . We subsequently re-
ported on the correlation of structural features of
phosphomannans and phosphomannan hydrolysis
fragments with their ability to inhibit enzyme pi-
nocytosis (15) . These results indicated (a) that
mannose-6-phosphate in some macromolecules is
more inhibitory than free mannose-6-phosphate,
(b) that phosphate in monoester linkage is a more
potent inhibitor than phosphate in diester linkage,
(c) that a large molecular weight polyphospho-
monoester (PPME) fragment of the phosphoman-
nan from the yeast Hansenula holstii (NRRL Y-
2448) is a very potent inhibitor of enzyme pino-
cytosis, and (d) that alkaline phosphatase treat-
ment of this phosphomonoester fragment reduces
its inhibitory potency in proportion to the phos-
phate released .
In the present paper, we report studies examin-
ing products of acid hydrolysis ofH . holstii phos-
phomannans for their potency as inhibitors of
enzyme pinocytosis, and for their susceptibility to
pinocytosis by fibroblasts . These studies show (a)
that the multivalent, large molecular weight PPME
fragment from H. holstii phosphomannan is a
much more potent inhibitor ofenzyme pinocytosis
than a monovalent pentamannosyl-monophos-
phate fragment from the same yeast phosphoman-
nan, (b) that the multivalent, large molecular
weight PPME fragment is subject to adsorptive
pinocytosis by fibroblasts while the smaller frag-
ment is not, (c) that the uptake ofthe large PPME
fragment is competitively inhibited by purified
high-uptake fl-glucuronidase, and (d) that the in-
hibition of phosphomannan pinocytosis by R-glu-
curonidase is destroyed by prior treatment of the
enzyme with either alkaline phosphatase or en-
doglycosidase-H . These results suggest that the
large molecular weight phosphomannan fragment
is pinocytosed by the previously reported system
for receptor-mediated uptake of acid hydrolases
and illustrate how phosphomannan fragments
may be useful as ligands for studies of the fibro-
blast pinocytosis receptor for lysosomal hydro-
lases . `
' Preliminary portions of the present work were pre-
sented as an abstract at the meeting of the Federation of
American Societies For Experimental Biology in Dallas,
Texas, April 1-5, 1979 .MATERIALS AND METHODS
Most reagents were purchased from Sigma Chemical Co., St .
Louis, Mo. H. holstii mannan andphosphomannan were gifts of
Dr .M. Slodki. Uniformly labeledH. holstii["C]phosphomannan
(--3 .0 x 10'" cpm/mol organic phosphate) was obtained as
previously described (5) . Saccharomyces cerevisiaephosphoman-
nan (X2180-mnn1) was the gift of Dr . C. E. Ballou. Homogene-
ous Escherichia coli alkaline phosphatase was a gift of Dr. M.
Schlesinger . Cultured fibroblasts were established from skin
biopsies obtained from patient J . E. with /3-glucuronidase defi-
ciency mucopolysaccharidosis (available as cell strain GM-151
from the Human Mutant Cell Repository, Camden, N. J.) and
patient T. M. with I-cell disease (Division of Medical Genetics,
University of Texas Health Science Center, Dallas, Tex.) .
Hydrolysis ofPhosphomannan
A solution of native H . holstii phosphomannan was hydro-
lyzed in 0.1 N HCl for 20 min at 100°C . A pentamannosyl-
monophosphate fragment and a large molecular weight PPME
fragment were subsequently separated by column chromatogra-
phy on Bio-Gel-P2 (Bio-Rod Laboratories, Richmond, Calif.) .
"C-labeled phosphomannan fragments were separated as previ-
ously described (5).
Purification ofHuman Spleen i8-
Glucuronidase
High-uptake human spleen t3-glucuronidasewas isolated from
homogenates of human spleen by sequential applications of a
heat step, ammonium sulfateprecipitation, concanavalin A(Con-
A) column chromatography, gel filtration, and two successive
CM-Sephadex columns . The details of this procedure are pub-
lished elsewhere (18) . The /3-glucuronidase obtained appeared
pure on sodium dodecyl sulfate (SDS) slab gels. The properties
of the high-uptake enzyme purified from this source were no
different than those reported for high-uptake enzyme purified
from platelets (13) .
Alkaline Phosphatase Treatment
Most alkaline phosphatase treatments were carried out as
previously described (13) with E . coli alkaline phosphatase .
Treatments of thePPME were done for 24 h at 37°C with 401ig
of alkaline phosphatase/100 !lg of PPME . This treatment re-
moved >90% of the total organic phosphate on the PPME
fragment.
Endoglycosidase-H Treatment
Endoglycosidase-H treatments were carried out for 48 h at
37 ° C in 50 mM Na-acetate, 0.2 M citrate-P04 buffer, pH 5.5,
with a total of20mU of endoglycosidase-H (Miles Laboratories,
Inc ., Elkhart, Ind.) . The protein was subsequently precipitated
with 80% ice-cold ethanol, and thereleased oligosaccharides were
recovered from the supernate .
Pinocytosis Measurements
Fibroblasts were grown in Eagle'sminimum essential medium
with Earle's salts (KC Biological) supplemented with IS% heat-
inactivated fetal bovine serum and 3 mM glutamine . Pinocytosis
rates for a-glucuronidase and ['"C]phosphomannan were deter-
mined in duplicate 35-mm petri dishes (Falcon Labware, Div.
Becton, Dickinson Co ., Oxnard, Calif) containing --2.5 x 105'
cells at confluence (-0.2 mg protein/dish). The cells were ex-
posed to the indicated concentrations ofenzyme or phosphoman-
nan (t inhibitors) in 1.0 ml of this medium and incubated at
37°C for 2.0 h (enzyme) or 24 h (phosphomannan) . The cells
were then washed six times with 3-ml portions of ice-cold, PBS
and lysed with 0.5 ml of 2% sodium deoxycholate .
Assays
Phosphatewas determined by the Ames method (1) . /3-Glu-
curonidase was assayed as previously described using 10 mM 4-
methylumbelliferyl-glucuronide (9) . 1 U of enzyme activity is
defined as the activity which releases 1 nmol of4-methylumbel-
liferone/h . Radioactivity was counted in 10 ml of Biofluor (New
England Nuclear, Boston, Mass.) . Protein was determined by the
method ofLowry et al . (17).
RESULTS
"Mild acid-hydrolysis conditions" (0.01-0 .1 N
HCl at 100°C for 15-20 min) selectively cleave
phosphodiester bonds in yeast cell-wall phospho-
mannans (4) . The 6-phosphomonoester groups ex-
posed by this treatment are far more resistant to
acid hydrolysis . In fact, the t1 /2 for 6-phospho-
mannose monoester bonds is 1,034 min in 1 .0 N
HCl at 100°C (16) . Thus, the 6-phosphomannose
monoester phosphate largely resists acid hydroly-
sis conditions strong enough to hydrolyze man-
nans completely to monosaccharides .
Mild acid hydrolysis of native extracellular H.
holstii phosphomannan produces two predominant
phosphomannosyl species . One is a highly
branched, large molecular weight PPME fragment
composed solely of mannose and phosphate in a
molar ratio of -5.7 :1 (23) . The other is a smaller
molecular weight pentamannosyl monophosphate,
(Man)5-P, having the structure P-6-Mana(1 --+ 3)
Mana(l --+ 3) Mana(1-+ 3) Mana(1 --+ 2) Man (5),
and which can be viewed as a monovalent ligand
with a single 6-phosphomonoester of mannose at
the nonreducing end of the molecule . By compar-
ison of the number ofreducing groups per mole of
phosphate on the PPME and (Man)5-P using 3H-
NaBH4 reduction (7), the average size of the
PPME fragment was estimated to be 1,000 times
larger than that of (Man) 5-P (Fischer and Sly,
unpublished observations) . This suggests a molec-
ular weight of ^-1 X 106 for the PPME fragment
which can thus be viewed as a multivalent ligand
containing nearly 1,000 phosphate groups/mole-
cule .
Since nearly all (90-95%) of the phosphate pres-
ent in the PPME is released by prolonged treat-
ment with alkaline phosphatase, and since man-
nose-6-phosphate is the only phosphorylated sugar
produced by strong acid hydrolysis of the PPME
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fragment is thought to be present as the 6-phos-
phomonoester of mannose . Slodki et al. (23) have
shown by periodate oxidation analysis that
a(1-> 2) and a(1--+ 6)-linked mannose residues
are present in the PPME . The same group has
more recently shown by methylation analysis that
all ---> 3)-linked residues are also present and that
a significant number of nonreducing end groups
results from 1,2,6-tri-O-substituted points of
branching (Slodki, personal communication) . As
acetolysis, which selectively cleaves (1 --+ 6) link-
ages, of dephosphorylated PPME produced only
short oligosaccharides of mannose (Monaghan
and Bretthauer, unpublished observations), the
structure of the PPME could consist of a linear
a(1--* 6)-linkedpolymannose backbone with short
oligosaccharide side chains linked all -- 2) to the
main chain which contain all~2) and all --+ 3)-
linked mannose residues, some of which are phos-
phorylated at the 6-position . Further experimen-
tation is required to more precisely define the
structure of the PPME.
Fig . 1 shows the relative potency of (Man)5-P
and the PPME fragment as inhibitors ofR-glucu-
ronidase pinocytosis by fibroblasts . While the
monovalent (Man);P displays nearly the same
inhibitory potency previously described for man-
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FIGURE 1
￿
Concentration dependence of inhibition of
enzyme pinocytosis by H . holslii phosphomannan hy-
drolysis fragments . Pinocytosis was measured with 1,000
U of human spleen R-glucuronidase as described under
Materials and Methods . Phosphate in the abscissa refers
to concentration of organic phosphate in the fragments .
Cells were confluent 35-mm dishes of,8-glucuronidase-
deficient fibroblasts . (") Large molecular weight PPME
fragment, (/) pentamannosyl-monophosphate fragment .
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nose-6-phosphate (14), the large molecular weight,
multivalent PPME is in excess of 100-fold more
potent per mole oforganic phosphate (or 100,000-
fold more potent per molecule) as an inhibitor of
enzyme pinocytosis than is (Man),,P.
Strong acid hydrolysis reduces yeast mannans
to monosaccharides . In the case ofH . holstii phos-
phomannan, theproducts of strong acid hydrolysis
are mannose and mannose-6-phosphate (22) . Fig .
2 displays the effect of strong acid hydrolysis of
the PPME on its ability to inhibit P-glucuronidase
pinocytosis . Fig . 2A shows the time and concen-
tration dependence of loss of inhibitory potency
on acid hydrolysis . Nearly all of the inhibitory
capacity is destroyed by hydrolysis in 1.0 N HCl
at 100°C for 1.0 h . Fig . 2B indicates that with acid
hydrolysis conditions under which the glycosidic
bonds are hydrolyzed but the phosphate monces-
ter bond is relatively stable (16), the inhibitory
capacity of the PPME is rapidly reduced to the
level of potency for free mannose-6-phosphate .
Further hydrolysis is very slow and comparable to
the rate of hydrolysis of mannose 6-phosphate .
These results suggest that the large initial loss in
potency is not due to hydrolysis of the phosphate
bond but rather to destruction of some secondary
feature of the PPME molecule .
Data comparing the relative abilities of the
PPME and (Man)5-P fragments from "Glabeled
H. holstii phosphomannan to bind to andbe taken
up by human 1-cell disease fibroblasts are pre-
sented in Fig . 3 . Fig . 3A demonstrates that the
binding, per mole ofphosphate, of the large, mul-
tivalent PPME at 3°C is much more efficient than
that of the small, monovalent (Man)5-P . A Scat-
chard analysis of these data (not shown) indicates
that the affmity constants for thesetwoligands are
nearly equal to their inhibitory constants for en-
zyme uptake and suggest that there are 6,000
PPME binding sites on fibroblasts . Fig . 3B shows
that the multivalent PPME is also taken up much
more efficiently than monovalent (Man),.,-P after
incubation with fibroblasts for24 h at 37°C . Even
at a concentration 100-fold greater than the high-
est shown in Fig . 3B (i .e ., concentrations where
(Man);P is an effective inhibitor of enzyme pi-
nocytosis), uptake of (Man)5-P wasno greater than
that explainable by nonspecific, fluid endocytosis
(0 .3 pl/mg/h) . Trypsinization of fibroblasts for 5
min at 37 °C with 0.05% trypsin after binding of
PPME for 2 h at 3°C released -90% of the cell-
associated radioactivity, while nearly all of the
radioactivity associated with cells incubated with0
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FIGURE 2
￿
Effect of acid hydrolysis at 100°C on inhibitory potency ofH . holstii phosphomannan PPME
fragment for /3-glucuronidase pinocytosis . Pinocytosis was measured as described under Materials and
Methods with P-glucuronidase-deficient fibroblasts . Phosphomannan and Man-6-P concentrations were
5 x 10-5M organicphosphate . (A) Acid normality, (A) 0.1 N HCI, (A)0.25N HCI, (") 0.5 N HCl, (")
l .0 N HCl, (B) Hydrolysis -fPPME and Man-6-P with 0.5 N HC1. (" ) 5 x 10-5M (PO") PPME, (O) 5
x 10-5M Man-6-P.
the PPME for 24 h at 37°C was insensitive to
release by trypsin and assumed to be internalized
(data not shown) .
I-Cell disease fibroblasts, which are deficient for
multiple acid hydrolases, were chosen for these
studies to minimize degradation of the ligands
after pinocytosis. The data in Fig. 4 indicate that
under our assay conditions for PPME pinocytosis
by human fibroblasts, uptake over 24 h approxi-
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FIGURE 3
￿
Binding and pinocytosis by 1-cell disease fibroblastsoflarge molecular weightPPME fragment
and pentamannosyl-monophosphate from H. holstii by 1-cell disease fibroblasts. Both fragments isolated
from ['"C]mannose-labeled H. holstii phosphomannan (30,000cpm/nmol organic PO,) . (A)3°Cbinding
of phosphomannan fragments . Binding was carried out on ice in a cold room in a total volume of 1 ml/
petri dish for 2 h . Concentration is expressed as organic phosphate concentration . Cpm-bound refers to
the amount of radioactivity which becomes cell-associated at 3°C and remains cell associated after six
washes with PBS at 4°C. 90% of the cpm bound were released by trypsin treatment- (see text) . Specific
binding refers to the amount of binding by "C-labeled phosphomannan fragments which is inhibited by
a 100-fold excess of unlabeled ligand. (B) Pinocytosis measurement was as described in Materials and
Methods . Phosphomannan fragment concentration is expressed as organic phosphate concentration . (" )
PPME, (O) (Man),-P .
mates linearity, and little of the material internal-
ized over the first 24 h by I-cell disease fibroblasts
was lost to the medium over the next 24 h. Al-
though (Man);P was internalized at a much
slower rate than PPME, its stability, once takenup
by 1-cell fibroblasts, was similar to that of PPME .
Less than 5% of the '"C-(Man)5;P accumulated by
1-cell fibroblasts during a 24-h incubation was lost
to the medium over the next 24 h (datanot shown) .
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FIGURE 4
￿
Time course of '"C-PPME uptake and dis-
appearance in 1-cell disease fibroblasts . (A) Pinocytosis
measured as in Materials and Methods. PPME concen-
tration was 1 .0 x 10-s M organic phosphate (-x30,000
cpm) . (B) Disappearance of pinocytosed PPME . Cells
were preloaded for 24 h with PPME as described . Plates
were then washed four times with uptake medium, fresh
medium was added, and the cells were incubated at 37°C
for the indicated times . Plates were then washed and
assayed as described in Materials and Methods .
If the greater efficiency of the larger molecular
weight ligand is a consequence of its ability to
interact as a multivalent ligand, one might expect
to see inhibition of its pinocytosis at high ligand
concentrations analogous to the inhibition of an-
tibody precipitin reactions in the region of high
antibody excess. Fig . 5 demonstrates such an in-
hibition ofPPME pinocytosis at high ligand con-
centrations.We interpret this as specific "substrate
inhibition" of pinocytosis since greater than ten-
fold higher concentrations of other polyanions
(chondroitin sulfate, heparin sulfate, polyglutamic
acid, and sodium phosphate glasses) had no effect
on PPME pinocytosis (data not shown) .
It was previously reported (15) that alkaline
phosphatase treatment of the PPME diminished
its potency as an inhibitor of a-glucuronidase pi-
nocytosis . Table Ishows that alkaline phosphatase
treatment of the PPME also reduces its ability to
be pinocytosed by fibroblasts. The effect of the
alkaline phosphatase is sensitive to inhibition by
inorganic phosphate and was completely inhibit-
able by I mM Pi . Table I also presents data
showing that two potent inhibitors (13) of lyso-
somal enzyme pinocytosis, mannose 6-phosphate
and mild acid hydrolyzed S. cerevisiae X2180-
mnn- I mannan (4), also inhibit PPME pinocytosis.
A nonphosphorylated mannan produced by H .
holstii grown in phosphate-free media (22) is non-
inhibitory for PPME uptake, however. Fig . 6 pre-
sents data showing inhibition ofPPME pinocytosis
by two compounds which were previously dem-
onstrated to be competitive inhibitors of/3-glucu-
ronidase pinocytosis (13) . These data suggest a
common binding site for these inhibitors and the
PPME fragment and a common mechanism for
pinocytosis of lysosomal hydrolases and the
PPME .
The possibility thatPPME and,8-glucuronidase
are pinocytosed by a common fibroblast receptor
was examined in an experiment in which PPME
uptake was inhibited by the addition of purified
human spleen /8-glucuronidase to the uptake me-
dium . Fig . 7A shows the effect of increasing con-
centration of added R-glucuronidase on the inhi-
bition of PPME uptake by fibroblasts. The data
presented in Fig . 7B show that the inhibition of
PPME pinocytosis by the added enzyme is com-
petitive, as would be expected if pinocytosis of
both ligands required binding to the same recep-
tor .
Alkaline phosphatase treatmentof spleen /3-glu-
curonidase destroys its ability to be pinocytosed
by fibroblasts (14) . The data in Table II demon-
strate this previously reported effect of alkaline
phosphatase treatmenton the uptake properties of
humanspleen enzyme, andshow, in addition, that
this treatment also reduces the ability of the en-
zyme to inhibit the pinocytosis of PPME . These
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FIGURE 5
￿
Inhibition ofPPME pinocytosis at high sub-
strate concentrations ."C-PPMEwas diluted tenfold with
unlabeled PPME and pinocytosis was measured as de-
scribed in Materialsand Methods . The phosphomannan
concentrations, expressed as organic phosphate concen-
tration, indicate the total concentration ofPPME in the
incubation mixture and a constant ratio of radiolabeled
to unlabeled PPME at each point.results are in accord with thepreviously suggested
role of a 6-phosphomannose group in the recog-
nition marker for lysosomal hydrolase uptake by
fibroblasts, and suggest a similar role for 6-phos-
phomannose in the recognition and pinocytosis of
PPME by fibroblasts .
Finally, Natowicz et al. have shown that endo-
glycosidase-H treatmentofspleen,8-glucuronidase
quantitatively released oligosaccharide chains con-
taining 6-phosphomannose (18) . High-uptake en-
zyme contained up to 4.4 mol of Man-6-P/mol of
enzyme, and release of the Man-6-P by endogly-
cosidase-H destroyed the susceptibility of the en-
zyme to pinocytosis by fibroblasts (18). We rea-
soned that if high-uptake enzyme containing mul-
tiple 6-phosphomannose groups/enzyme molecule
interacts as a multivalent ligand with fibroblast
pinocytosis receptors, its effectiveness as an inhib-
itor of PPME pinocytosis should depend on the
presence of the 6-phosphomannose in a multiva-
lent form (i.e ., on theenzyme).6-Phosphomannose
containing oligosaccharides released by endogly-
cosidase-H would be expected to be much less
effective inhibitors ofPPME uptake, analogous to
the 100-fold loss ofinhibitory potency for enzyme
pinocytosis found in conversion ofPPME to man-
nose-6-phosphate . The data in Table III demon-
TABLE I
Effect of Prior Alkaline Phosphatase Treatment and
Enzyme Pinocytosis Inhibitors on t'C-PPME Uptake
Pinocytosis measured as in Materials and Methods .
PPME concentration = 1.0 x 10-6 M organic phos-
phate.
$ Phosphomamman from S. cerevisiae mutant X2180-
mnn l hydrolyzed for 15 min at 100°C in 0.1 N HC1 .
§Nonphosphorylated mannan from H. holstii grown in
phophate deficient media.
DISCUSSION
5 .10, 1.0.101 1,5
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FIGURE 6
￿
Double reciprocal plot of the effect of t°C-
PPME concentration on '°C-PPME pinocytosis in the
absence and presence of inhibitors . Pinocytosis was
measured as described in Materialsand Methods except
that the indicated concentrations ofPPME and inhibitor
were used . (") no additions, (A) +0 .5 mg/ml acid hy-
drolyzed (20 min at 100°C with 0.1 N HCl) X2180-mnn-
I Mannan, (p) +1.0 mg/ml acid hydrolyzed X2180-
mnn-l-mannan, (O) +1 .0 mM Man-6-P .
strate the effect of endoglycosidase-H treatment
on the uptake properties of human spleen /3-glu-
curonidase, and show in addition that this treat-
ment also reduces the ability of the enzyme to
inhibit pinocytosis of PPME. Moreover, the 6-
phosphomannose containing oligosaccharides of
spleen a-glucuronidase are much less inhibitory
for PPME uptake when released by endoglycosi-
dase-H than when present on the enzyme .
Strong acid hydrolysis reducesH . holstiiphospho-
mannan to mannose and 6-phosphomannose (22) .
The potency of the strong acid hydrolysate as an
inhibitor of enzyme pinocytosis was comparable
to that expected from its 6-phosphomannose con-
tent . Hydrolysates produced by mild acid treat-
ment, however, had far greater inhibitory potency
than that expected from their 6-phosphomannose
content . The two principal products in mild acid
hydrolysates, the monovalent pentamannosyl-
monophosphate, (Man)5-P and the largemolecular
83
Added Inhibitor
Pinocytosis
cpm/mg/
24 h
ofPPME'
% Inhibi-
tion
None 6,145 -
ImM Man-6-P 2,382 61 .2
0.5 mg/ml Phosphomannan$ 2,975 51 .6
0.5 mg/ml Mannan§ 6,133 0.2
Prior Treatment
Pinocytosis
cpm/mg/
24 h
ofPPME'
% Inhibi-
tion
None 6,145 -
Alkaline phosphatase 1,997 67 .5
Alkaline phosphatase + 1 mM Pi 6,149 0.084
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FIGURE 7
￿
Inhibition of '"C-PPME pinocytosis by purified spleen /3-glucuronidase . Pinocytosis measure-
ments were as described in Materials and Methods . (A) Concentration dependence of the inhibition of
PPME pinocytosis by ß-glucuronidase . PPME concentration equivalent to 0.1 x 10- `M organic phosphate
(3,000 cpm) . (B) Double reciprocal plot ofeffect ofPPME concentration on phosphomannan pinocytosis
by human I-cell disease fibroblasts in presence and absence of human spleen /3-glucuronidase . (") no
addition, (O) +50,000 U/ml spleen ,ß-glucuronidase .
TABLE II
Effect of Prior Alkaline Phosphatase Treatment on
the Pinocytosis Rate and on the Inhibitory Potency of
Spleen P-Glucuronidase for '"C-PPME Pinocytosis
Pinocytosis of /3-glucuroni-
dase*
Inhibi-
Treatment
￿
U/mg/h tion
None
+Alkaline phosphatase
77 .0 -
16 .5 79
* Measured as described in Materials and Methods with
1,000 U/ml ß-glucuronidase .
$ Measured as described in Materials and Methods with
PPME concentration of 0.1 x 10- ' M organic phos-
phate .
weight, multivalent PPME, were separated by gel
chromatography and shown to be quite different
from each other in their potency as pinocytosis
inhibitors . The large molecularweight PPME frag-
ment, which contained many exposed 6-phos-
phomannose groups, was nearly 100-fold more
potent as an inhibitor per mole of organic phos-
phate (100,000-fold more potent per molecule) .
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TABLE III
Effect ofPrior Endoglycosidase-H Treatment on Pi-
nocytosis Rate and on the Inhibitory Potency of
Spleen ,ß-Glucuronidase for "C-PPME Pinocytosis
Treatment
None
+Endoglycosidase-H
+Oligosaccharides released by
endoglycosidase-H from
60,000 U spleen /3-glucuroni-
dase
Pinocytosis of i3-glucuron-
idase*
U/mg/h
￿
% Inhibition
87 .6 -
2 .1 97 .6
* Measured as described in Materials and Methods with
1,000 U/ml,6-glucuronidase .
$ Measured as described in Materials and Methods with
PPME concentration of 0.25 x l0-b M organic phos-
phate .
Although (Man)5-P and PPME both showed
saturable binding to fibroblasts at 3°C, thebinding
per mole of phosphate of the large, multivalent
PPME was much more efficient that that of the
small, monovalent pentamannosyl-monophos-
Inhibitor
Pinocytosis
cpm/mg/
24 h
of PPME$
%.Inhibi-
tion
Inhibitor
None
Pinocytosis
cpm/mg/
24 h
4,529
ofPPME$
% Inhibition
-
None 1,146 - +60,000 U spleen /3-glucuroni- 2,544 43 .8
+50,000 U ß-glucuronidase 417 63 .6 dase
+50,000 U alkaline phospha- 1,142 0.3 +60,000 U endoglycosidase-H 4,144 8 .5
tase treated /3-glucuronidase treated spleen ,ß-glucuronidase
4,489 0 .9phate. These two phosphomannan fragments also
differed in their susceptibility to pinocytosis by
fibroblasts . The rate and kinetics of uptake of the
pentamannosyl-monophosphate suggest that it is
taken up only by nonspecific fluid-phase endocy-
tosis . Its rate of uptake is comparable to that for
"'I-albumin and is less than threefold the rate of
[3H]methoxydextran uptake (14), two markers for
fluid-phase endocytosis which gave rate estimates
of 0.5 and 0.15 [,1/mg/h, respectively, for this
process in fibroblasts . As with these nonspecific
fluid-phase pinocytosis markers, the rate of
(Man),,-P uptake was linearly dependent on its
concentration in the medium . Thus, although
(Man) 5-P is an inhibitor of adsorptive pinocytosis
of acid hydrolases, it is very poorly taken up by
the process it inhibits. In contrast, the large molec-
ular weight PPME fragment appears to be taken
up by adsorptive pinocytosis . The PPME uptake
process is saturable . At low ligand concentrations,
its rate of uptake is at least 30-fold greater than
can be explained by the rate of fluid-phase endo-
cytosis as estimated with ` 25I-albumin . As seen in
Fig . 5, concentrations ofPPME significantly above
that required for saturation of binding actually
inhibited pinocytosis . The apparent substrate in-
hibition ofPPME uptake at high concentrations is
consistent with pinocytosis ofa multivalent ligand .
The simplest interpretation for the differences
in inhibitory potency and susceptibility to pino-
cytosis between pentamannosyl-monophosphate
and PPME is that the PPME is a multivalent
ligand which interacts with multiple receptors on
the surface of fibroblasts . If this is indeed the
fundamental difference between these two ligands,
one might then infer that a monovalent interaction
with 6-phosphomannose or pentamannosylmon-
ophosphate does not lead to internalization of
these ligands, whereas a multivalent interaction of
the PPME with one ormany pinocytosis receptors
does induce pinocytosis of the ligand .
Multivalent ligands could be taken up more
rapidly for two reasons . First, multivalency could
confer higher affinity of binding leading to a
greater fraction ofoccupied receptors at low ligand
concentrations . Secondly, multivalent ligands
might actually stimulate adsorptive pinocytosis by
cross-linking more than one receptor .
There are several precedents for multivalency in
the recognition and uptake of ligands by cell sur-
face receptors . Ash and Singer (2) have shown that
the tetravalent lectin Con A induces a clustering
of bound cell surface receptors which are then
collected into a few large patches or a single "cap"
on the cell surface . During and after the capping
process, the bound ligands are internalized by
endocytosis of the capped regions of the mem-
brane . If divalent succinylated-Con A is added to
cells, however, the clustering and capping of
bound receptors fails to occur. In this case, capping
can subsequently be induced if the cells that have
been reacted with succinylated-Con A are further
reacted with antibodies to the lectin . Similarly, the
effective capping of Fab fragments specific for the
T25 antigen and the H2 antigen on lymphocytes
requires a second cross-linking antibody (24) .
The evidence that uptake of the multivalent
PPME ligand depends on the same receptors that
mediate internalization of acid hydrolases is con-
siderable . The uptake of both the PPME and acid
hydrolases is diminished by prior treatment of
these ligands with alkaline phosphatase . Similarly,
the uptake of both the PPME and acid hydrolases
is competitively inhibited by mannose-6-phos-
phate and mild acid-hydrolyzed phosphomannan
from S . cerevisiae mutant X2180 mnn-1, but is not
inhibited by a nonphosphorylated H. holstii man-
nan . Moreover, just as the PPME competitively
inhibits the pinocytosis of purified high-uptake
human /3-glucuronidase by fibroblasts, so also is
the pinocytosis of the PPME fragment competi-
tively inhibited by the high-uptake enzyme .
The suggestion that the same pinocytosis recep-
tors are involved in pinocytosis of lysosomal en-
zymes and the multivalent PPME phosphoman-
nan fragment of H. holstii raises an interesting
question concerning the pinocytosis of lysosomal
hydrolases, i.e ., are acid hydrolases multivalent
ligands which induce their own pinocytosis by
binding to multiple cell surface receptors? One can
easily visualize how an acid hydrolase such as
human /3-glucuronidase could be a multivalent
ligand. The enzyme is a glycoprotein and appears
to be a tetramer of identical 75,000-mol wt sub-
units (6) . As such, a multivalent interaction with
several cell surface receptors could result from any
of several possibilities : (a) through an interaction
of single 6-phosphomannose groups on different
protein subunits ; (b) through each subunit having
more than one oligosaccharide chain, each of
which could bear a 6-phosphomannose moiety; (c)
multiple 6-phosphomannose moieties could be
present on a single oligosaccharide chain. We have
demonstrated up to 4.4 mol of 6-phosphoman-
nose/mol high-uptake enzyme, and a direct cor-
relation between the 6-phosphomannose content
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fractions of R-glucuronidase isolated from spleen
(18) .
While it is clear that acid hydrolases could be
multivalent ligands and that their pinocytosis
could depend on an interaction with multiple pi-
nocytosis receptors, an alternate possibility is that
high-uptake acid hydrolases are monovalent lig-
ands which bind to pinocytosis receptors with
much higher affinity than 6-phosphomannose due
to some other structural feature ofthe recognition
marker . In this case, pinocytosis ofthe multivalent
PPME phosphomannan fragment could simply
result from its binding to and cross-linking multi-
ple acid hydrolase receptors . However, the obser-
vations that thepotencyofhigh-uptake enzyme as
an inhibitor ofPPME pinocytosis is dramatically
reduced by an endoglycosidase-H treatment that
releases the phosphomannosyl-containing oligo-
saccharides from the enzyme is certainly compat-
ible with the idea that high-uptake enzyme acts as
a multivalent ligand .
Since multivalent H . holstii PPME fragments
arepinocytosedby thesame receptors that mediate
uptake of acid hydrolases by fibroblasts, theymay
prove useful ligands in the analysis of the fibro-
blast pinocytosis receptor for lysosomal hydro-
lases . Moreover, they can probably be covalently
attached to enzymes and other agents to target
these compounds for uptake by cell types which
express the phosphomannosyl-enzyme pinocytosis
receptors .
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